Pulmonary hypertension
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients diagnosed with pulmonary arterial hypertension according to the "Chinese Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension (2021 Edition)," and who are categorized as having low to intermediate risk; 2) Left heart disease diagnoses include ischemic heart disease, hypertension, heart failure, and valvular heart disease; 3) Age =18 years; 4) Capable of understanding the experiment and willing to sign the informed consent form, voluntarily participate, and demonstrate good compliance.
Exclusion criteria
Exclusion criteria: 1) Patients with severe systemic organ diseases or infectious disease history, in critical condition, unstable vital signs, and a clinical life expectancy of less than 1 year; 2) Patients with contraindications to TTE, unable to undergo TTE for measuring pulmonary artery pressure; 3) Patients allergic to electrode patches, unable to tolerate; 4) Patients with neuropsychiatric disorders, poor compliance;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time difference image (?Zq); | — |
Countries
China
Contacts
Affiliated Hospital of Hangzhou Normal University